Cargando…

The management of cardiovascular disease in the Netherlands: analysis of different programmes

BACKGROUND: Disease management programmes are increasingly used to improve the efficacy and effectiveness of chronic care delivery. But, disease management programme development and implementation is a complex undertaking that requires effective decision-making. Choices made in the earliest phases o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cramm, Jane M., Tsiachristas, Apostolos, Walters, Bethany H., Adams, Samantha A., Bal, Roland, Huijsman, Robbert, Rutten-Van Mölken, Maureen P.M.H., Nieboer, Anna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Igitur publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807633/
https://www.ncbi.nlm.nih.gov/pubmed/24167456
_version_ 1782288495896690688
author Cramm, Jane M.
Tsiachristas, Apostolos
Walters, Bethany H.
Adams, Samantha A.
Bal, Roland
Huijsman, Robbert
Rutten-Van Mölken, Maureen P.M.H.
Nieboer, Anna P.
author_facet Cramm, Jane M.
Tsiachristas, Apostolos
Walters, Bethany H.
Adams, Samantha A.
Bal, Roland
Huijsman, Robbert
Rutten-Van Mölken, Maureen P.M.H.
Nieboer, Anna P.
author_sort Cramm, Jane M.
collection PubMed
description BACKGROUND: Disease management programmes are increasingly used to improve the efficacy and effectiveness of chronic care delivery. But, disease management programme development and implementation is a complex undertaking that requires effective decision-making. Choices made in the earliest phases of programme development are crucial, as they ultimately impact costs, outcomes and sustainability. METHODS: To increase our understanding of the choices that primary healthcare practices face when implementing such programmes and to stimulate successful implementation and sustainability, we compared the early implementation of eight cardiovascular disease management programmes initiated and managed by healthcare practices in various regions of the Netherlands. Using a mixed-methods design, we identified differences in and challenges to programme implementation in terms of context, patient characteristics, disease management level, healthcare utilisation costs, development costs and health-related quality of life. RESULTS: Shifting to a multidisciplinary, patient-centred care pathway approach to disease management is demanding for organisations, professionals and patients, and is especially vulnerable when sustainable change is the goal. Funding is an important barrier to sustainable implementation of cardiovascular disease management programmes, although development costs of the individual programmes varied considerably in relation to the length of the development period. The large number of professionals involved in combination with duration of programme development was the largest cost drivers. While Information and Communication Technology systems to support the new care pathways did not directly contribute to higher costs, delays in implementation indirectly did. CONCLUSIONS: Developing and implementing cardiovascular disease management programmes is time-consuming and challenging. Multidisciplinary, patient-centred care demands multifaceted changes in routine care. As care pathways become more complex, they also become more expensive. Better preparedness and training can prevent unnecessary delays during the implementation period and are crucial to reducing costs.
format Online
Article
Text
id pubmed-3807633
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Igitur publishing
record_format MEDLINE/PubMed
spelling pubmed-38076332013-10-28 The management of cardiovascular disease in the Netherlands: analysis of different programmes Cramm, Jane M. Tsiachristas, Apostolos Walters, Bethany H. Adams, Samantha A. Bal, Roland Huijsman, Robbert Rutten-Van Mölken, Maureen P.M.H. Nieboer, Anna P. Int J Integr Care Integrated Care Pathways BACKGROUND: Disease management programmes are increasingly used to improve the efficacy and effectiveness of chronic care delivery. But, disease management programme development and implementation is a complex undertaking that requires effective decision-making. Choices made in the earliest phases of programme development are crucial, as they ultimately impact costs, outcomes and sustainability. METHODS: To increase our understanding of the choices that primary healthcare practices face when implementing such programmes and to stimulate successful implementation and sustainability, we compared the early implementation of eight cardiovascular disease management programmes initiated and managed by healthcare practices in various regions of the Netherlands. Using a mixed-methods design, we identified differences in and challenges to programme implementation in terms of context, patient characteristics, disease management level, healthcare utilisation costs, development costs and health-related quality of life. RESULTS: Shifting to a multidisciplinary, patient-centred care pathway approach to disease management is demanding for organisations, professionals and patients, and is especially vulnerable when sustainable change is the goal. Funding is an important barrier to sustainable implementation of cardiovascular disease management programmes, although development costs of the individual programmes varied considerably in relation to the length of the development period. The large number of professionals involved in combination with duration of programme development was the largest cost drivers. While Information and Communication Technology systems to support the new care pathways did not directly contribute to higher costs, delays in implementation indirectly did. CONCLUSIONS: Developing and implementing cardiovascular disease management programmes is time-consuming and challenging. Multidisciplinary, patient-centred care demands multifaceted changes in routine care. As care pathways become more complex, they also become more expensive. Better preparedness and training can prevent unnecessary delays during the implementation period and are crucial to reducing costs. Igitur publishing 2013-08-07 /pmc/articles/PMC3807633/ /pubmed/24167456 Text en Copyright 2013, Authors retain the copyright of their article http://creativecommons.org/licenses/by/3.0/ This work is licensed under a (http://creativecommons.org/licenses/by/3.0) Creative Commons Attribution 3.0 Unported License
spellingShingle Integrated Care Pathways
Cramm, Jane M.
Tsiachristas, Apostolos
Walters, Bethany H.
Adams, Samantha A.
Bal, Roland
Huijsman, Robbert
Rutten-Van Mölken, Maureen P.M.H.
Nieboer, Anna P.
The management of cardiovascular disease in the Netherlands: analysis of different programmes
title The management of cardiovascular disease in the Netherlands: analysis of different programmes
title_full The management of cardiovascular disease in the Netherlands: analysis of different programmes
title_fullStr The management of cardiovascular disease in the Netherlands: analysis of different programmes
title_full_unstemmed The management of cardiovascular disease in the Netherlands: analysis of different programmes
title_short The management of cardiovascular disease in the Netherlands: analysis of different programmes
title_sort management of cardiovascular disease in the netherlands: analysis of different programmes
topic Integrated Care Pathways
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807633/
https://www.ncbi.nlm.nih.gov/pubmed/24167456
work_keys_str_mv AT crammjanem themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT tsiachristasapostolos themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT waltersbethanyh themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT adamssamanthaa themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT balroland themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT huijsmanrobbert themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT ruttenvanmolkenmaureenpmh themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT nieboerannap themanagementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT crammjanem managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT tsiachristasapostolos managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT waltersbethanyh managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT adamssamanthaa managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT balroland managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT huijsmanrobbert managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT ruttenvanmolkenmaureenpmh managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes
AT nieboerannap managementofcardiovasculardiseaseinthenetherlandsanalysisofdifferentprogrammes